624 related articles for article (PubMed ID: 9888708)
1. Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features.
Baldassano MF; Bailey EM; Ferry JA; Harris NL; Duncan LM
Am J Surg Pathol; 1999 Jan; 23(1):88-96. PubMed ID: 9888708
[TBL] [Abstract][Full Text] [Related]
2. Differential diagnosis of cutaneous infiltrates of B lymphocytes with follicular growth pattern.
Leinweber B; Colli C; Chott A; Kerl H; Cerroni L
Am J Dermatopathol; 2004 Feb; 26(1):4-13. PubMed ID: 14726817
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma.
Cerroni L; Signoretti S; Höfler G; Annessi G; Pütz B; Lackinger E; Metze D; Giannetti A; Kerl H
Am J Surg Pathol; 1997 Nov; 21(11):1307-15. PubMed ID: 9351568
[TBL] [Abstract][Full Text] [Related]
4. Automated kappa and lambda light chain mRNA expression for the assessment of B-cell clonality in cutaneous B-cell infiltrates: its utility and diagnostic application.
Magro C; Crowson AN; Porcu P; Nuovo GJ
J Cutan Pathol; 2003 Sep; 30(8):504-11. PubMed ID: 12950502
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.
de Leval L; Harris NL; Longtine J; Ferry JA; Duncan LM
Am J Surg Pathol; 2001 Jun; 25(6):732-41. PubMed ID: 11395550
[TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases.
Servitje O; Gallardo F; Estrach T; Pujol RM; Blanco A; Fernández-Sevilla A; Pétriz L; Peyrí J; Romagosa V
Br J Dermatol; 2002 Dec; 147(6):1147-58. PubMed ID: 12452864
[TBL] [Abstract][Full Text] [Related]
7. A review of 55 cases of cutaneous lymphoid hyperplasia: reassessment of the histopathologic findings leading to reclassification of 4 lesions as cutaneous marginal zone lymphoma and 19 as pseudolymphomatous folliculitis.
Arai E; Shimizu M; Hirose T
Hum Pathol; 2005 May; 36(5):505-11. PubMed ID: 15948117
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic reassessment of primary cutaneous B-cell lymphomas with immunophenotypic and molecular genetic characterization.
Yang B; Tubbs RR; Finn W; Carlson A; Pettay J; Hsi ED
Am J Surg Pathol; 2000 May; 24(5):694-702. PubMed ID: 10800988
[TBL] [Abstract][Full Text] [Related]
9. B-cell cutaneous lymphoid hyperplasia representing progressive transformation of germinal center: a report of 2 cases.
Kojima M; Sakurai S; Shimizu K; Itoh H
Int J Surg Pathol; 2010 Oct; 18(5):429-32. PubMed ID: 18815203
[TBL] [Abstract][Full Text] [Related]
10. Extranodal marginal zone B-cell lymphoma of the skin: a morphologic and immunophenotypic study of 11 cases.
Tomaszewski MM; Abbondanzo SL; Lupton GP
Am J Dermatopathol; 2000 Jun; 22(3):205-11. PubMed ID: 10871062
[TBL] [Abstract][Full Text] [Related]
11. Re-evaluation of "reactive lymphoid hyperplasia of the uvea": an immunohistochemical and molecular analysis of 10 cases.
Cockerham GC; Hidayat AA; Bijwaard KE; Sheng ZM
Ophthalmology; 2000 Jan; 107(1):151-8. PubMed ID: 10647734
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of cutaneous marginal zone lymphomas with marked plasmacytic differentiation and a T cell-rich background.
Geyer JT; Ferry JA; Longtine JA; Flotte TJ; Harris NL; Zukerberg LR
Am J Clin Pathol; 2010 Jan; 133(1):59-69. PubMed ID: 20023259
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous lymphoid hyperplasia. Immunologic characteristics and assessment of criteria recently proposed as diagnostic of malignant lymphoma.
Medeiros LJ; Picker LJ; Abel EA; Hu CH; Hoppe RT; Warnke RA; Wood GS
J Am Acad Dermatol; 1989 Nov; 21(5 Pt 1):929-42. PubMed ID: 2808829
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathologic study of primary marginal zone B-cell lymphoma of MALT type and lymphoid hyperplasia of lung].
Feng RE; Tian XL; Liu HR; Ling Q; Zhong DR; Luo YF; Cao JL; Wan JW; Zhu YJ
Zhonghua Bing Li Xue Za Zhi; 2008 Mar; 37(3):155-9. PubMed ID: 18788590
[TBL] [Abstract][Full Text] [Related]
15. PD-1, S-100 and CD1a expression in pseudolymphomatous folliculitis, primary cutaneous marginal zone B-cell lymphoma (MALT lymphoma) and cutaneous lymphoid hyperplasia.
Goyal A; Moore JB; Gimbel D; Carter JB; Kroshinsky D; Ferry JA; Harris NL; Duncan LM
J Cutan Pathol; 2015 Jan; 42(1):6-15. PubMed ID: 25384543
[TBL] [Abstract][Full Text] [Related]
16. Lupus profundus, indeterminate lymphocytic lobular panniculitis and subcutaneous T-cell lymphoma: a spectrum of subcuticular T-cell lymphoid dyscrasia.
Magro CM; Crowson AN; Kovatich AJ; Burns F
J Cutan Pathol; 2001 May; 28(5):235-47. PubMed ID: 11401667
[TBL] [Abstract][Full Text] [Related]
17. Mantle zone lymphoma: an immunohistologic study of skin lesions.
Bertero M; Novelli M; Fierro MT; Bernengo MG
J Am Acad Dermatol; 1994 Jan; 30(1):23-30. PubMed ID: 8277026
[TBL] [Abstract][Full Text] [Related]
18. B-zone small lymphocytic lymphoma: a morphologic, immunophenotypic, and clinical study with comparison to "well-differentiated" lymphocytic disorders.
Carbone A; Pinto A; Gloghini A; Volpe R; Zagonel V
Hum Pathol; 1992 Apr; 23(4):438-48. PubMed ID: 1563746
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous reactive B-cell lymphoid proliferations.
Khalil S; Donthi D; Gru AA
J Cutan Pathol; 2022 Oct; 49(10):898-916. PubMed ID: 35656820
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic index: discriminant feature for the differentiation of cutaneous diffuse malignant follicular center cell lymphomas from lymphoid hyperplasia.
Miracco C; Spina D; Santopietro R; Sforza V; Leoncini L; Pacenti L; de Santi MM; Lio R; Luzi P; Tosi P
J Invest Dermatol; 1993 May; 100(5):699-704. PubMed ID: 8491993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
